Displaying drugs 251 - 275 of 406 in total
| Name | Weight | Structure | Desription | Categories |
|---|---|---|---|---|
| Mosunetuzumab | 146300.0 C6515H10031N1725O2025S43 |  | A humanized anti-CD20/CD3 bispecific antibody used to treat relapsed or refractory follicular lymphoma. | Amino Acids, Peptides, and Proteins / Antibodies, Monoclonal / Antibodies, Monoclonal, Humanized / Antineoplastic Agents / Blood Proteins / Cancer immunotherapy / CD20-directed Antibody Interactions / CD3-directed Antibody Interactions / Immunoglobulins / Immunosuppressive Agents / Immunotherapy / Myelosuppressive Agents / Proteins / Serum Globulins |
| Motixafortide | 2159.6 C97H144FN33O19S2 | | A peptide inhibitor of CXCR4 used to mobilize hematopoietic stem cells prior to collection and autologous transplantation in multiple myeloma patients. | Amino Acids, Peptides, and Proteins / Hematopoietic Stem Cell Mobilizer / Peptides |
| Moxetumomab pasudotox | 63500.0 C2804H4339N783O870S14 |  | A CD22-specific antibody conjugated to a truncated exotoxin used to treat relapsed or refractory hairy cell leukemia in patients who have already been treated with a purine nucleoside analog and one other treatment. | CD22 (Clusters of Differentiation 22) inhibitors |
| Muromonab | 146189.7 C6460H9946N1720O2043S56 |  | A monoclonal anti-CD3 antibody used as immunosuppressive therapy in kidney, heart, and liver transplant patients. | Selective Immunosuppressants |
| Natalizumab | 149000.0 |  | A monoclonal anti-integrin antibody used to treat Crohn's disease or multiple sclerosis. | Selective Immunosuppressants |
| Naxitamab | 144000.0 | | A GD2-targeted IgG1 monoclonal antibody for the treatment of high-risk relapsed/refractory neuroblastoma of the bone or bone marrow. | Glycolipid Disialoganglioside-directed Antibody |
| Necitumumab | Not Available |  | A monoclonal antibody used to treat metastatic squamous non-small cell lung cancer. | Antibodies, Monoclonal / EGFR (Epidermal Growth Factor Receptor) inhibitors |
| Nesiritide | 3464.0 |  | A recombinant natriuretic peptide used for the treatment of patients with acutely decompensated congestive heart failure who have dyspnea at rest or with minimal activity. | Natriuretic Agents / Natriuretic Peptide, Brain / Natriuretic Peptides / Nerve Tissue Proteins |
| Neuropeptide Y | Not Annotated | | Neuropeptide Y is under investigation for the basic science of Type 2 Diabetes Mellitus. | Neuropeptide Y, drug effects / Neuropeptides |
| Nirsevimab | 146300.0 C6494H10060N1708O2050S46 | | A long-acting monoclonal antibody indicated for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and infants. | Antiviral monoclonal antibodies |
| Nivolumab | 143597.3811 C6362H9862N1712O1995S42 |  | A PD-1 blocking antibody used to treat melanoma, non small-cell lung cancer, renal cell cancer, head and neck cancer, and Hodgkin lymphoma. | Antibodies, Monoclonal / PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors |
| Obiltoxaximab | 148000.0 | | A monoclonal antibody used for prophylaxis or treatment of inhalational anthrax. | Antibacterial monoclonal antibodies / Specific Immunoglobulins |
| Obinutuzumab | 146100.0 C6512H10060N1712O2020S44 |  | An antineoplastic CD20 antibody used to treat untreated chronic lymphocytic leukemia in combination with chlorambucil. | Antibodies, Monoclonal / CD20 (Clusters of Differentiation 20) inhibitors |
| Ocrelizumab | 145000.0 C6494H9978N1718O2014S46 | | A CD20 specific monoclonal antibody used to treat relapsing remitting multiple sclerosis. | Selective Immunosuppressants |
| Ocriplasmin | 27250.0 C1214H1890N338O348S14 | | A proteolytic enzyme used to treat symptomatic vitreomacular adhesion by dissolving the protein matrix responsible for the adhesion between the vitreous and macula. | Peptide Hydrolases |
| Octreotide | Not Available | | A peptide drug used to treat acromegaly as well as diarrhea associated with metastatic carcinoid tumors and vasoactive intestinal peptide secreting tumors. | Antineoplastic Agents, Hormonal / Gastrointestinal Agents / Peptides, Cyclic / Somatostatin and Analogues |
| Odesivimab | 146164.54 C6506H10024N1720O2030S42 | | Part of a product containing three monoclonal IgG1κ antibodies directed against the GP1,2 glycoprotein of Zaire ebolavirus. Together, these three antibodies act to neutralize viral particles and to recruit immune effectors for the destruction of both viral particles and infected cells. | Antiviral Agents |
| Ofatumumab | 146100.0 C6480H10022N1742O2020S44 |  | An anti-CD20 antibody used for the treatment of chronic lymphocytic leukemia (CLL) in selected patients with certain treatment histories and responsiveness to anticancer medications. | Antibodies, Monoclonal / CD20 (Clusters of Differentiation 20) inhibitors / Selective Immunosuppressants |
| Olaratumab | 154000.0 C6554H10076N1736O2048S40 | | A platelet-derived growth factor receptor alpha blocking antibody used with doxorubicin to treat patients with certain types of soft tissue sarcoma (STS). | Antibodies, Monoclonal |
| Olipudase alfa | 63590.933 C2900H4373N783O791S24 | | A recombinant human acid sphingomyelinase used to treat Acid Sphingomyelinase Deficiency (ASMD) in children and adults. | Alimentary Tract and Metabolism / Amino Acids, Peptides, and Proteins / Enzyme Replacement Therapy / Enzymes / Enzymes and Coenzymes / Esterases / Hydrolases / Phosphoric Diester Hydrolases / Proteins / Recombinant Proteins |
| Omalizumab | 149000.0 |  | A monoclonal anti-immunoglobulin E (IgE) antibody used to treat asthma, chronic idiopathic urticaria, chronic rhinosinusitis with nasal polyps, and IgE-mediated food allergy. | Anti-Allergic Agents / Anti-Asthmatic Agents / Anti-IgE / Antibodies, Monoclonal, Humanized |
| Oprelvekin | 19047.2 C854H1411N253O235S2 |  | A form of recombinant interleukin-11 used to stimulate production of megakaryocytes and platelets in patients with or at risk of thrombocytopenia after chemotherapy. | Interleukins |
| Oxytocin | 1007.187 C43H66N12O12S2 |  | A recombinant hormone used to induce or strengthen uterine contractions in pregnant women to aid in labor and delivery or to control postpartum bleeding. | Oxytocin and Analogues |
| Palifermin | 16192.7 C721H1142N202O204S9 |  | A form of recombinant human keratinocyte growth factor used to prevent and treat oral mucositis following radiation or chemotherapy. | Detoxifying Agents for Antineoplastic Treatment |
| Palivizumab | Not Available |  | A monoclonal anti respiratory syncytial virus F protein antibody used to prevent serious sequelae caused by respiratory syncytial virus infection in pediatric patients. | Antiviral monoclonal antibodies / Specific Immunoglobulins |
Displaying drugs 251 - 275 of 406 in total